BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 23592770)

  • 1. Survival outcomes of breast cancer patients who receive neoadjuvant chemotherapy: association with dynamic contrast-enhanced MR imaging with computer-aided evaluation.
    Yi A; Cho N; Im SA; Chang JM; Kim SJ; Moon HG; Han W; Park IA; Noh DY; Moon WK
    Radiology; 2013 Sep; 268(3):662-72. PubMed ID: 23592770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of dynamic contrast-enhanced MR imaging to predict survival in patients with primary breast cancer undergoing neoadjuvant chemotherapy.
    Li SP; Makris A; Beresford MJ; Taylor NJ; Ah-See ML; Stirling JJ; d'Arcy JA; Collins DJ; Kozarski R; Padhani AR
    Radiology; 2011 Jul; 260(1):68-78. PubMed ID: 21502383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Background parenchymal signal enhancement ratio at preoperative MR imaging: association with subsequent local recurrence in patients with ductal carcinoma in situ after breast conservation surgery.
    Kim SA; Cho N; Ryu EB; Seo M; Bae MS; Chang JM; Moon WK
    Radiology; 2014 Mar; 270(3):699-707. PubMed ID: 24126372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Breast cancer: early prediction of response to neoadjuvant chemotherapy using parametric response maps for MR imaging.
    Cho N; Im SA; Park IA; Lee KH; Li M; Han W; Noh DY; Moon WK
    Radiology; 2014 Aug; 272(2):385-96. PubMed ID: 24738612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Computer-aided Diagnosis-generated Kinetic Features of Breast Cancer at Preoperative MR Imaging: Association with Disease-free Survival of Patients with Primary Operable Invasive Breast Cancer.
    Kim JJ; Kim JY; Kang HJ; Shin JK; Kang T; Lee SW; Bae YT
    Radiology; 2017 Jul; 284(1):45-54. PubMed ID: 28253106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breast MR imaging screening in women with a history of breast conservation therapy.
    Gweon HM; Cho N; Han W; Yi A; Moon HG; Noh DY; Moon WK
    Radiology; 2014 Aug; 272(2):366-73. PubMed ID: 24635678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary human breast adenocarcinoma: imaging and histologic correlates of intrinsic susceptibility-weighted MR imaging before and during chemotherapy.
    Li SP; Taylor NJ; Makris A; Ah-See ML; Beresford MJ; Stirling JJ; d'Arcy JA; Collins DJ; Padhani AR
    Radiology; 2010 Dec; 257(3):643-52. PubMed ID: 20858850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Invasive breast carcinoma: influence of prognosis and patient-related factors on kinetic MR imaging characteristics.
    Millet I; Curros-Doyon F; Molinari N; Bouic-Pages E; Prat X; Alili C; Taourel P
    Radiology; 2014 Jan; 270(1):57-66. PubMed ID: 24029641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rectal cancer: MR imaging before neoadjuvant chemotherapy and radiation therapy for prediction of tumor-free circumferential resection margins and long-term survival.
    Wieder HA; Rosenberg R; Lordick F; Geinitz H; Beer A; Becker K; Woertler K; Dobritz M; Siewert JR; Rummeny EJ; Stollfuss JC
    Radiology; 2007 Jun; 243(3):744-51. PubMed ID: 17463134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contralateral lesions detected by preoperative MRI in patients with recently diagnosed breast cancer: application of MR CAD in differentiation of benign and malignant lesions.
    Cho N; Kim SM; Park JS; Jang M; Kim SY; Chang JM; Moon WK
    Eur J Radiol; 2012 Jul; 81(7):1520-6. PubMed ID: 21498016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of pretreatment dynamic contrast-enhanced MR imaging in breast cancer patients receiving neoadjuvant chemotherapy: overall survival predicted from combined time course and volume analysis.
    Heldahl MG; Bathen TF; Rydland J; Kvistad KA; Lundgren S; Gribbestad IS; Goa PE
    Acta Radiol; 2010 Jul; 51(6):604-12. PubMed ID: 20429756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pretreatment MR Imaging Features of Triple-Negative Breast Cancer: Association with Response to Neoadjuvant Chemotherapy and Recurrence-Free Survival.
    Bae MS; Shin SU; Ryu HS; Han W; Im SA; Park IA; Noh DY; Moon WK
    Radiology; 2016 Nov; 281(2):392-400. PubMed ID: 27195438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contrast-enhanced MR mammography for evaluation of the contralateral breast in patients with diagnosed unilateral breast cancer or high-risk lesions.
    Pediconi F; Catalano C; Roselli A; Padula S; Altomari F; Moriconi E; Pronio AM; Kirchin MA; Passariello R
    Radiology; 2007 Jun; 243(3):670-80. PubMed ID: 17446524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the Tumor Response After Neoadjuvant Chemotherapy in Breast Cancer Patients: Correlation Between Dynamic Contrast-enhanced Magnetic Resonance Imaging and Pathologic Tumor Cellularity.
    Choi WJ; Kim WK; Shin HJ; Cha JH; Chae EY; Kim HH
    Clin Breast Cancer; 2018 Feb; 18(1):e115-e121. PubMed ID: 28890184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preoperative dynamic breast magnetic resonance imaging kinetic features using computer-aided diagnosis: Association with survival outcome and tumor aggressiveness in patients with invasive breast cancer.
    Nam SY; Ko ES; Lim Y; Han BK; Ko EY; Choi JS; Lee JE
    PLoS One; 2018; 13(4):e0195756. PubMed ID: 29649266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breast MR imaging: computer-aided evaluation program for discriminating benign from malignant lesions.
    Williams TC; DeMartini WB; Partridge SC; Peacock S; Lehman CD
    Radiology; 2007 Jul; 244(1):94-103. PubMed ID: 17507720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early Stage Triple-Negative Breast Cancer: Imaging and Clinical-Pathologic Factors Associated with Recurrence.
    Bae MS; Moon HG; Han W; Noh DY; Ryu HS; Park IA; Chang JM; Cho N; Moon WK
    Radiology; 2016 Feb; 278(2):356-64. PubMed ID: 26230976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoimmune pancreatitis: pancreatic and extrapancreatic MR imaging-MR cholangiopancreatography findings at diagnosis, after steroid therapy, and at recurrence.
    Manfredi R; Frulloni L; Mantovani W; Bonatti M; Graziani R; Pozzi Mucelli R
    Radiology; 2011 Aug; 260(2):428-36. PubMed ID: 21613442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value DCE-MRI parameters in predicting factor disease free survival and overall survival for breast cancer patients.
    Tuncbilek N; Tokatli F; Altaner S; Sezer A; Türe M; Omurlu IK; Temizoz O
    Eur J Radiol; 2012 May; 81(5):863-7. PubMed ID: 21398061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Background Parenchymal Enhancement on Preoperative Magnetic Resonance Imaging: Association With Recurrence-Free Survival in Breast Cancer Patients Treated With Neoadjuvant Chemotherapy.
    Choi JS; Ko ES; Ko EY; Han BK; Nam SJ
    Medicine (Baltimore); 2016 Mar; 95(9):e3000. PubMed ID: 26945421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.